Remove Drug Development Remove Healthcare Innovation Remove Healthcare IT Remove Pharmaceuticals
article thumbnail

Revolutionizing Medical AI Development: Flywheel Announces $54 Million in Series D Funding led by Novalis LifeSciences and NVentures

Healthcare IT Today

“Flywheel’s products transform healthcare innovation by empowering organizations to efficiently and securely ingest, curate and share medical imaging data for accelerated research and AI development,” said Flywheel CEO, Jim Olson.